Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Two Medicaid health plans' models and motivations for improving colorectal cancer screening rates.

Coury JK, Schneider JL, Green BB, Baldwin LM, Petrik AF, Rivelli JS, Schwartz MR, Coronado GD.

Transl Behav Med. 2018 Nov 16. doi: 10.1093/tbm/iby094. [Epub ahead of print]

PMID:
30445511
2.

Effectiveness of automated and live phone reminders after mailed-FIT outreach in a pilot randomized trial.

Nielson CM, Rivelli JS, Fuoco MJ, Gawlik VR, Jimenez R, Petrik AF, Coronado GD.

Prev Med Rep. 2018 Oct 17;12:210-213. doi: 10.1016/j.pmedr.2018.10.012. eCollection 2018 Dec.

3.

Positive predictive values of fecal immunochemical tests used in the STOP CRC pragmatic trial.

Nielson CM, Petrik AF, Jacob L, Vollmer WM, Keast EM, Schneider JL, Rivelli JS, Kapka TJ, Meenan RT, Mummadi RR, Green BB, Coronado GD.

Cancer Med. 2018 Sep;7(9):4781-4790. doi: 10.1002/cam4.1727. Epub 2018 Aug 13.

4.

Effectiveness of a Mailed Colorectal Cancer Screening Outreach Program in Community Health Clinics: The STOP CRC Cluster Randomized Clinical Trial.

Coronado GD, Petrik AF, Vollmer WM, Taplin SH, Keast EM, Fields S, Green BB.

JAMA Intern Med. 2018 Sep 1;178(9):1174-1181. doi: 10.1001/jamainternmed.2018.3629.

PMID:
30083752
5.

Mapping Multi-Site Clinic Workflows to Design Systems-Enabled Interventions.

Coronado GD, Retecki S, Petrik AF, Coury J, Aguirre J, Taplin SH, Burdick T, Green BB.

EGEMS (Wash DC). 2017 Jun 14;5(1):13. doi: 10.5334/egems.219.

6.

Participatory Research to Advance Colon Cancer Prevention (PROMPT): Study protocol for a pragmatic trial.

Thompson JH, Davis MM, Leo MC, Schneider JL, Smith DH, Petrik AF, Castillo M, Younger B, Coronado GD.

Contemp Clin Trials. 2018 Apr;67:11-15. doi: 10.1016/j.cct.2018.02.001. Epub 2018 Feb 9.

7.

Effect of Reminding Patients to Complete Fecal Immunochemical Testing: A Comparative Effectiveness Study of Automated and Live Approaches.

Coronado GD, Rivelli JS, Fuoco MJ, Vollmer WM, Petrik AF, Keast E, Barker S, Topalanchik E, Jimenez R.

J Gen Intern Med. 2018 Jan;33(1):72-78. doi: 10.1007/s11606-017-4184-x. Epub 2017 Oct 10.

8.

Predictors of Colorectal Cancer Screening Prior to Implementation of a Large Pragmatic Trial in Federally Qualified Health Centers.

Petrik AF, Le T, Keast E, Rivelli J, Bigler K, Green B, Vollmer WM, Coronado G.

J Community Health. 2018 Feb;43(1):128-136. doi: 10.1007/s10900-017-0395-7.

PMID:
28744716
9.

Applying the Plan-Do-Study-Act (PDSA) approach to a large pragmatic study involving safety net clinics.

Coury J, Schneider JL, Rivelli JS, Petrik AF, Seibel E, D'Agostini B, Taplin SH, Green BB, Coronado GD.

BMC Health Serv Res. 2017 Jun 19;17(1):411. doi: 10.1186/s12913-017-2364-3.

10.

Predicting 5-Year Risk of RRT in Stage 3 or 4 CKD: Development and External Validation.

Schroeder EB, Yang X, Thorp ML, Arnold BM, Tabano DC, Petrik AF, Smith DH, Platt RW, Johnson ES.

Clin J Am Soc Nephrol. 2017 Jan 6;12(1):87-94. doi: 10.2215/CJN.01290216. Epub 2016 Dec 27.

11.

The validation of electronic health records in accurately identifying patients eligible for colorectal cancer screening in safety net clinics.

Petrik AF, Green BB, Vollmer WM, Le T, Bachman B, Keast E, Rivelli J, Coronado GD.

Fam Pract. 2016 Dec;33(6):639-643. Epub 2016 Jul 28.

12.

Timeliness of Colonoscopy After Abnormal Fecal Test Results in a Safety Net Practice.

Oluloro A, Petrik AF, Turner A, Kapka T, Rivelli J, Carney PA, Saha S, Coronado GD.

J Community Health. 2016 Aug;41(4):864-70. doi: 10.1007/s10900-016-0165-y.

13.

Predicting the Risk of Clostridium difficile Infection upon Admission: A Score to Identify Patients for Antimicrobial Stewardship Efforts.

Kuntz JL, Smith DH, Petrik AF, Yang X, Thorp ML, Barton T, Barton K, Labreche M, Spindel SJ, Johnson ES.

Perm J. 2016 Winter;20(1):20-5. doi: 10.7812/TPP/15-049.

14.

Reasons for non-response to a direct-mailed FIT kit program: lessons learned from a pragmatic colorectal-cancer screening study in a federally sponsored health center.

Coronado GD, Schneider JL, Sanchez JJ, Petrik AF, Green B.

Transl Behav Med. 2015 Mar;5(1):60-7. doi: 10.1007/s13142-014-0276-x.

15.

Predicting the risk of Clostridium difficile infection following an outpatient visit: development and external validation of a pragmatic, prognostic risk score.

Kuntz JL, Johnson ES, Raebel MA, Platt RW, Petrik AF, Yang X, Thorp ML, Spindel SJ, Neil N, Smith DH.

Clin Microbiol Infect. 2015 Mar;21(3):256-62. doi: 10.1016/j.cmi.2014.11.001. Epub 2014 Nov 11.

16.

Health Policy to Promote Colorectal Cancer Screening: Improving Access and Aligning Federal and State Incentives.

Coronado GD, Petrik AF, Bartelmann SE, Coyner LA, Coury J.

Clin Res (Alex). 2015 Feb;29(1):50-55. Epub 2015 Feb 1.

17.

Clinical perspectives on colorectal cancer screening at Latino-serving federally qualified health centers.

Coronado GD, Petrik AF, Spofford M, Talbot J, Do HH, Taylor VM.

Health Educ Behav. 2015 Feb;42(1):26-31. doi: 10.1177/1090198114537061. Epub 2014 Jun 20.

18.

Individuality of the plasma sodium concentration.

Zhang Z, Duckart J, Slatore CG, Fu Y, Petrik AF, Thorp ML, Cohen DM.

Am J Physiol Renal Physiol. 2014 Jun 15;306(12):F1534-43. doi: 10.1152/ajprenal.00585.2013. Epub 2014 Apr 9.

19.

Should measuring haemoglobin among chronic kidney disease patients be a performance measure?

Thorp ML, Smith DH, Johnson ES, Weiss JW, Vupputuri S, Petrik AF, Yang XH.

J Evid Based Med. 2012 Nov;5(4):194-204. doi: 10.1111/jebm.12005.

PMID:
23557499
20.

Predicting costs of care in heart failure patients.

Smith DH, Johnson ES, Blough DK, Thorp ML, Yang X, Petrik AF, Crispell KA.

BMC Health Serv Res. 2012 Nov 30;12:434. doi: 10.1186/1472-6963-12-434.

21.

Clinician's use of automated reports of estimated glomerular filtration rate: a qualitative study.

Smith DH, Schneider J, Thorp ML, Vupputuri S, Weiss JW, Johnson ES, Feldstein A, Petrik AF, Yang X, Snyder SR.

BMC Nephrol. 2012 Nov 23;13:154. doi: 10.1186/1471-2369-13-154.

22.

Correlates of higher-dose opioid medication use for low back pain in primary care.

Kobus AM, Smith DH, Morasco BJ, Johnson ES, Yang X, Petrik AF, Deyo RA.

J Pain. 2012 Nov;13(11):1131-8. doi: 10.1016/j.jpain.2012.09.003.

23.

Epidemiology and healthcare costs of incident Clostridium difficile infections identified in the outpatient healthcare setting.

Kuntz JL, Johnson ES, Raebel MA, Petrik AF, Yang X, Thorp ML, Spindel SJ, Neil N, Smith DH.

Infect Control Hosp Epidemiol. 2012 Oct;33(10):1031-8. doi: 10.1086/667733. Epub 2012 Aug 23.

PMID:
22961023
24.

Proteinuria among patients with chronic kidney disease: a performance measure for improving patient outcomes.

Thorp ML, Smith DH, Johnson ES, Vupputuri S, Weiss JW, Petrik AF, Yang X, Levey AS, Wasse H, Muoneke R, Snyder SR.

Jt Comm J Qual Patient Saf. 2012 Jun;38(6):277-82. Review.

PMID:
22737779
25.

Clostridium difficile infection, Colorado and the northwestern United States, 2007.

Kuntz JL, Johnson ES, Raebel MA, Petrik AF, Yang X, Thorp ML, Spindel SJ, Neil N, Smith DH.

Emerg Infect Dis. 2012 Jun;18(6):960-2. doi: 10.3201/eid1806.111528.

26.

Predicting chronic kidney disease outcomes: are two estimated glomerular filtration rates better than one?

DeVille J, Smith DH, Johnson ES, Yang X, Petrik AF, Weiss JR, Thorp ML.

Popul Health Manag. 2012 Apr;15(2):113-8. doi: 10.1089/pop.2011.0012. Epub 2012 Feb 7.

PMID:
22313437
27.

Opioids for back pain patients: primary care prescribing patterns and use of services.

Deyo RA, Smith DH, Johnson ES, Donovan M, Tillotson CJ, Yang X, Petrik AF, Dobscha SK.

J Am Board Fam Med. 2011 Nov-Dec;24(6):717-27. doi: 10.3122/jabfm.2011.06.100232.

28.

An economic evaluation of a laboratory monitoring program for renin-angiotensin system agents.

Smith DH, Raebel MA, Chan KA, Johnson ES, Petrik AF, Weiss JR, Yang X, Feldstein A.

Med Decis Making. 2011 Mar-Apr;31(2):315-24. doi: 10.1177/0272989X10379918.

PMID:
21393563
29.

Integrating clinical trial findings into practice through risk stratification: the case of heart failure management.

Smith DH, Johnson ES, Thorp ML, Crispell KA, Yang X, Petrik AF.

Popul Health Manag. 2010 Jun;13(3):123-9. doi: 10.1089/pop.2009.0047.

PMID:
20455788
30.

Energy transfer ligands of the GluR2 ligand binding core.

Petrik AF, Strub MP, Lee JC.

Biochemistry. 2010 Mar 9;49(9):2051-7. doi: 10.1021/bi9020007.

31.

Predicting the risk of hyperkalemia in patients with chronic kidney disease starting lisinopril.

Johnson ES, Weinstein JR, Thorp ML, Platt RW, Petrik AF, Yang X, Anderson S, Smith DH.

Pharmacoepidemiol Drug Saf. 2010 Mar;19(3):266-72. doi: 10.1002/pds.1923.

32.

Effect of anaemia on mortality, cardiovascular hospitalizations and end-stage renal disease among patients with chronic kidney disease.

Thorp ML, Johnson ES, Yang X, Petrik AF, Platt R, Smith DH.

Nephrology (Carlton). 2009 Apr;14(2):240-6. doi: 10.1111/j.1440-1797.2008.01065.x.

PMID:
19207866

Supplemental Content

Loading ...
Support Center